evaluating of clobetasol 0.05% and doxepine 5% cream vs clobetasol 0.05% and placebo in the treatment of moderate to severe hand eczema
Phase 1
- Conditions
- hand eczema.Other atopic dermatitis
- Registration Number
- IRCT201112018263N1
- Lead Sponsor
- ?Shahid Sadooghi University of Medical Sciences,Yazd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
all patients with moderate to severe hand eczema that are 12 to 70 years old
exclusion criteria:treatment with systemic steroid less than 1 month before trial;treatment with topical steroid and antihistamines at the time of presentation ;pregnancy;lactatation;age less than 12
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction or improvement of hand eczema. Timepoint: before and 8 days after treatment. Method of measurement: hand eczema severity index.
- Secondary Outcome Measures
Name Time Method Adverse effects. Timepoint: 8 days after initiation of treatment. Method of measurement: 8 days after initiation of treatment.